BiographyDr. Larson is an applied economist with the Department of International Health and the Center for Global Health and Development (CGHD). See the CGHD website, http://www.bu.edu/cghd/about-us/people/bruce-larson/, for information on recent and continuing research activities. Dr. Larson has conducted research activities in 25 countries over the past 20 years, mainly in Africa and the former Soviet Union. Before joining Boston University, Larson was an Associate Professor at the University of Connecticut, a Research Associate with the Harvard Institute for International Development, a Research Fellow with Winrock International, and an Agricultural Economist with the U.S. Department of Agriculture. As part of these activities, he was based in Tallinn and Moscow during 1994-1997 and Nairobi in 2005-2006. Note: The publications list below does not include publications outside of public health (e.g. agriculture, environment, development, international trade).
- University of Wisconsin-Madison, BA
- University of Wisconsin-Madison, MA
- University of Wisconsin-Madison, PhD
- Published on 8/11/2016
Larson BA, Ngoma T, Silumbe K, Rutagwera MR, Hamainza B, Winters AM, Miller JM, Scott CA. A framework for evaluating the costs of malaria elimination interventions: an application to reactive case detection in Southern Province of Zambia, 2014. Malar J. 2016; 15(1):408. PMID: 27515533.
- Published on 8/9/2016
Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med. 2016 Aug; 13(8):e1002106. PMID: 27505444.
- Published on 7/8/2016
Larson BA, Rockers PC, Bonawitz R, Sriruttan C, Glencross DK, Cassim N, Coetzee LM, Greene GS, Chiller TM, Vallabhaneni S, Long L, van Rensburg C, Govender NP. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016; 11(7):e0158986. PMID: 27390864.
- Published on 4/15/2015
Halim N, Spielman K, Larson B. The economic consequences of selected maternal and early childhood nutrition interventions in low- and middle-income countries: a review of the literature, 2000-2013. BMC Womens Health. 2015; 15:33. PMID: 25887257.
- Published on 3/16/2015
Larson B, Tindikahwa A, Mwidu G, Kibuuka H, Magala F. How much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda? PLoS One. 2015; 10(3):e0119484. PMID: 25774677.
- Published on 2/6/2015
Schnippel K, Mongwenyana C, Long LC, Larson BA. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis. BMC Infect Dis. 2015; 15:46. PMID: 25656597.
- Published on 12/15/2014
Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 1; 93(2):118-24. PMID: 25883405.
- Published on 12/5/2014
Larson BA, Lembela-Bwalya D, Bonawitz R, Hammond EE, Thea DM, Herlihy J. Finding a needle in the haystack: the costs and cost-effectiveness of syphilis diagnosis and treatment during pregnancy to prevent congenital syphilis in Kalomo District of Zambia. PLoS One. 2014; 9(12):e113868. PMID: 25478877.
- Published on 3/31/2014
Scott CA, Iyer HS, McCoy K, Moyo C, Long L, Larson BA, Rosen S. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study. BMC Public Health. 2014; 14:296. PMID: 24684772.
- Published on 3/10/2014
Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483. PMID: 24711925.
View 29 more publications:View full profile at BUMC